Validation of pain and patient global scales in chronic gout: Data from two randomised controlled trials

Annals of the Rheumatic Diseases

Volumn 70, Issue 7, 2011, Pages 1277-1281

  Singh, Jasvinder A ^a,b,c,d   Yang, Shuo ^b   Strand, Vibeke ^e   Simon, Lee ^f   Forsythe, Anna ^g   Hamburger, Steve ^g   Chen, Lang ^b  

^a BIRMINGHAM VA MEDICAL CENTER   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^e STANFORD UNIVERSITY   (United States)

^f SDG LLC   (United States)

^g Savient Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE; NONSTEROID ANTIINFLAMMATORY AGENT; PEGLOTICASE; PLACEBO; URATE;

ADULT; ARTHRALGIA; ARTICLE; CHRONIC DISEASE; COMORBIDITY; CONTROLLED STUDY; DISCRIMINANT VALIDITY; DISEASE DURATION; DISEASE EXACERBATION; DRUG RESPONSE; FEMALE; GOUT; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; JOINT SWELLING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHORT FORM 36; TREATMENT OUTCOME; URIC ACID BLOOD LEVEL; VALIDATION STUDY; VISUAL ANALOG SCALE;

ADULT; AGED; CHRONIC DISEASE; FEMALE; GOUT; GOUT SUPPRESSANTS; HUMANS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; POLYETHYLENE GLYCOLS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; URATE OXIDASE;

EID: 79957640681     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2010.144022     Document Type: Article

References (15)

1. Schumacher HR, Taylor W, Edwards L, et al. Outcome domains for studies of acute and chronic gout. J Rheumatol 2009;36:2342-5.
2. Strand CV, Khanna D, Singh JA, et al. Improved health-related quality of life and physical function in patients with refractory chronic gout following treatment with pegloticase. Arthritis Rheum ( In Press ).
3. Ware JE, Kosinski M, Dewey JE. How to Score Version 2 of the SF-36® Health Survey (Standard & Acute Forms). Second edition. Lincoln, RI: QualityMetric, Inc 2001.
4. Franzblau A. A Primer of Statistics for Non-statisticians. New York, NY: Harcourt Brace & World 1958.
5. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989;10:407-15.
6. Salaffi F, Stancati A, Silvestri CA, et al. Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. Eur J Pain 2004;8:283-91. (Pubitemid 38859657)
7. Salaffi F, Leardini G, Canesi B, et al. Reliability and validity of the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index in Italian patients with osteoarthritis of the knee. Osteoarthr Cartil 2003;11:551-60. (Pubitemid 36926530)
8. Hays RD, Farivar SS, Liu H. Approaches and recommendations for estimating minimally important differences for health-related quality of life measures. COPD 2005;2:63-7. (Pubitemid 40776225)
9. Wells G, Li T, Maxwell L, et al. Determining the minimal clinically important differences in activity, fatigue, and sleep quality in patients with rheumatoid arthritis. J Rheumatol 2007;34:280-9.
10. Wolfe F, Michaud K, Strand V. Expanding the definition of clinical differences: from minimally clinically important differences to really important differences. Analyses in 8931 patients with rheumatoid arthritis. J Rheumatol 2005;32:583-9. (Pubitemid 40524688)
11. Becker MA, Schumacher HR, Benjamin KL, et al. Quality of life and disability in patients with treatment-failure gout. J Rheumatol 2009;36:1041-8.
12. Singh JA, Strand V. Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans. Ann Rheum Dis 2008;67:1310-16.
13. Felson DT, Anderson JJ, Boers M, et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
14. Prevoo ML, van 't Hof MA, Kuper HH, et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
15. Farrar JT, Portenoy RK, Berlin JA, et al. Defining the clinically important difference in pain outcome measures. Pain 2000;88:287-94.